Patients with leukaemia, particularly those who become neutropenic during attempted remission induction of acute myeloid leukaemia, are at considerable risk of infection. Despite the advantages of protective isolation,12 prophylactic antibiotic therapy,3 4 and empirical antibiotic therapy,5 infection is the commonest cause of death. The diagnosis of infection is particularly difficult, moreover, when there are insufficient neutrophils to migrate to a site of infection to cause localising signs, and when previous antibiotic therapy hinders bacteriological isolation. The transfusion of blood, platelets, or granulocytes and the infusion of cytotoxic drugs may also induce pyrexia, thereby mimicking infection.
An earlier study of C-reactive protein (C-RP), using the 18-hour radial immunodiffusion technique, suggested that a serum level of above 100 mg/l indicated the presence of infection.6 Serial measurements of C-RP were carried out in the present study by the 1-hour laser nephelometric assay to determine the value of this rapid technique for detecting infection in leukaemic patients.
Patients and methods
Twenty-five adult inpatients with leukaemia (11 acute myeloblastic, 4 A standard curve was prepared for each batch of test sera. Diluted antiserum (1-0 ml) was pipetted into each of six Hyland nephelometer cuvettes (Travenol Laboratories, Thetford), 0-1 ml of each dilution of the standard was added, and the tube contents were mixed by inversion. Six blank tubes were similarly prepared by the addition of 01 ml of each dilution of the standard to 10 ml volumes of diluent without antiserum. The tuLbes were left at room temperature for 1 hour, and the nephelometer readings were then plotted arithmetically against concentration. TEST 
SERA
Patient sera were initially diluted 1/10 and 1/50 in 0 9 % w/v sodium chloride, and 0 1 ml aliquots were then pipetted into 10 ml diluted antiserum, mixed, and left for 1 hour as above. A blank tube was prepared for each test serum. All estimations were performed in duplicate on two successive days by one of LIs (MM), without access to clinical information, on either fresh or deep-frozen ( -20 C) sera. London specimens had thawed during transport to Birmingham and were re-frozen before assay in batches. There was no evidence, from the results of serial specimens, that haemolysis, re-freezing, or the age of the specimen influenced the results. Repeated thawing and freezing did sometimes result in the formation of a precipitate causing high blank values with minor loss of sensitivity. Lipaemic specimens resulted in high blank values which occasionally also reduced the sensitivity of the assay.
Results
Thirty-four episodes of infection were investigated. A positive blood culture was obtained in 13 episodes (Table 1) , and the C-RP level rose to above 100 mg/l in 10 of these. This rise preceded the date of a positive blood culture by one to four days in three episodes. In one of the three C-RP failures, the peak level reached 93 mg/l in a patient with a central venous line, a temperature of 39 C, and a Streptococcus 'iridans bacteraemia. The C-RP level again (Table 2 ). In nine of these 15 episodes, the C-RP was greater than 100 mg/ I for between one and 14 days before bacteriological or radiological confirmation of infection was obtained. In one failure, the patient had a previously elevated level above 100 mg/l for the previous 23 days as a consequence of recurrent episodes of arm and thigh cellulitis and also a tracheostomy. The development of left basal pneumonia 24 hours after tracheostomy was associated with a C-RP rise from 144 to 170 mg/l; the previous infection and postoperative acute-phase protein response undoubtedly influenced this poor response to new infection.
Bacteriological confirmation of clinically evident infection was not obtained in four other episodes; in these, a C-RP level above 100 mg/I was obtained in each case (Table 3) . 
Serial study of C-reactive protein during infection in leukaemia Discussion
This serial study provides additional support to the observation that C-RP levels of above 100 mg/l are of diagnostic value in leukaemic patients with suspected infection. 6 We now recommend that blood specimens be taken for assay, or for storage, whenever venepuncture is performed in the neutropenic patient; the stored sera may then be used to provide sequential results if pyrexia subsequently develops. The serial study of C-RP is of considerably greater value in diagnosis, and as a guide to therapy, than single estimations.
Elevation of C-RP did not always occur in parallel with a rise in temperature during episodes of infection. Pyrexia developed first in four episodes, and a rise in C-RP was an earlier indicator of infection in six episodes. A C-RP level greater than 100 mg/l in an apyrexial patient therefore justifies intensive search for a focus of infection. The results shown in Fig. 1 were obtained from a leukaemic patient who developed, on day 13, a thigh abscess from which Streptococcus faecalis and Staphylococcus aureus were isolated. Despite absence of pyrexia, the C-RP had been persistently greater than 100 mg/I.
In this example, the C-RP rise not only occurred in the absence of a temperature rise but also preceded clinical presentation of the infected lesion. Earlier antibiotic treatment could have been administered if the C-RP level had been used as an indicator of infection.
The clinical value of serial C-RP estimations is further illustrated in Figure 2 . This thrombocytopenic patient presented on day 0 with a swollen, tender thigh, which was initially diagnosed as an expanding haematoma. In a study of 50 bleeding episodes (12 haematomas and 38 haemarthroses) in patients with inherited bleeding disorders, however, the C-RP failed to reach 100 mg/l in any case. The elevated C-RP level, reaching 440 mg/l in (0) patient with a swollen thigh which could not be diagnosed as an abscess until day 10.
this patient, therefore indicated an infective cause for the swollen thigh. The swelling subsequently localised (day 10) to form a large abscess from which Staph. aureus was isolated and which responded to clindamycin. A further rise in C-RP level, when already greater than 100 mg/l, may reflect the development of new infection. Two patients who developed bacteraemia, and another with a thigh abscess, already had C-RP levels above 150 mg/i as a consequence of previous infection. A further rise of at least 100 mg/l occurred in all three in parallel with a new infection. The patient in Fig. 3 with alpha-haemolytic streptococcal pharyngitis on day 2 was not treated, despite neutropenia, in view of apparent spontaneous resolution. She was readmitted on day 14, four days after discharge, having developed an alphahaemolytic streptococcal septicaemia. The C-RP level during the first admission had been greater than 200 mg/i and rose to 480 mg/i with the development of septicaemia on readmission.
In other patients, the failure of a high C-RP level to fall below 100 mg/1, or indeed a continuing rise, indicated an inadequate response to antibiotics and a poor prognosis. The patient in Fig. 4 Although we have observed two patients with an extensive maculopurpuric rash, as a consequence of drug hypersensitivity, who developed a false-positive rise in C-RP level to above 100 mg/I, we have not observed a rise of this magnitude after the infusion of red cells, platelets, granulocytes, or cytotoxics even in the presence of a pyrexial reaction. On three occasions patients with pyrexia after cytotoxic infusion were given antibiotics unnecessarily since subsequent testing of stored sera showed no rise in C-RP level to above 100 mg/l and there was no clinical or microbiological evidence of infection.
Patients with active rheumatoid arthritis occasionally show a disproportionately low C-RP level and may be 'poor responders' (RA Crockson, personal communication). Two of our leukaemic patients failed to reach a C-RP level of 100 mg/i in each of two infective episodes, and one remained below 50 mg/I during a Strep. viridans bacteraemia. ' Poor responders' probably exist in diseases other than rheumatoid arthritis and constitute a group in whom C-RP is an inadequate test of infection. Such patients, however, are comparatively uncommon.
Infection should therefore be suspected in the leukaemic patient whenever the serum C-RP level already exceeds 100 mg/l on admission, subsequently rises above 100 mg/l, or increases further by 100 mg/I. The 1-hour laser nephelometric assay, compared with the 18-hour radial immunodiffusion technique, is sufficiently rapid to allow a clinical decision to be delayed until the assay result is available. Serial specimens should continue to be taken after antibiotic therapy has started in order to monitor the therapeutic response. A prospective trial is required to determine whether a fall in C-RP level to below 100 mg/l indicates that antibiotics can safely be stopped, and this is now in progress.
